Alpha DNA Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,655
| Closed | -$1.72M | – | 62 |
|
|
2024
Q4 | $1.72M | Buy |
4,655
+645
| +16% | +$238K | 0.65% | 33 |
|
|
2024
Q3 | $2.09M | Buy |
4,010
+232
| +6% | +$121K | 0.78% | 20 |
|
|
2024
Q2 | $2.05M | Sell |
3,778
-220
| -6% | -$119K | 0.8% | 23 |
|
|
2024
Q1 | $2.07M | Buy |
3,998
+2,179
| +120% | +$1.13M | 0.77% | 19 |
|
|
2023
Q4 | $858K | Sell |
1,819
-2,919
| -62% | -$1.38M | 0.33% | 55 |
|
|
2023
Q3 | $2.06M | Buy |
4,738
+28
| +0.6% | +$12.2K | 0.84% | 14 |
|
|
2023
Q2 | $2.09M | Buy |
4,710
+262
| +6% | +$116K | 0.7% | 19 |
|
|
2023
Q1 | $2.05M | Buy |
4,448
+1,256
| +39% | +$578K | 0.6% | 14 |
|
|
2022
Q4 | $1.64M | Buy |
3,192
+590
| +23% | +$303K | 0.58% | 24 |
|
|
2022
Q3 | $1.18M | Buy |
+2,602
| New | +$1.18M | 0.98% | 21 |
|